These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38353960)

  • 1. When It Comes to SARS-CoV-2 Clearance, People Who Are Immunocompromised Are Not All Alike.
    Rubin R
    JAMA; 2024 Mar; 331(9):723-724. PubMed ID: 38353960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.
    Borges V; Isidro J; Cunha M; Cochicho D; Martins L; Banha L; Figueiredo M; Rebelo L; Trindade MC; Duarte S; Vieira L; Alves MJ; Costa I; Guiomar R; Santos M; Cortê-Real R; Dias A; Póvoas D; Cabo J; Figueiredo C; Manata MJ; Maltez F; Gomes da Silva M; Gomes JP
    mSphere; 2021 Aug; 6(4):e0024421. PubMed ID: 34319130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 in Immunocompromised Patients: A Systematic Review.
    Stainer A; Amati F; Suigo G; Simonetta E; Gramegna A; Voza A; Aliberti S
    Semin Respir Crit Care Med; 2021 Dec; 42(6):839-858. PubMed ID: 34918325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COVID-19 Pandemic Rages on for People Who Are Immunocompromised.
    Rubin R
    JAMA; 2022 May; 327(19):1853-1855. PubMed ID: 35476006
    [No Abstract]   [Full Text] [Related]  

  • 5. Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection.
    Chavarot N; Leruez-Ville M; Scemla A; Burger C; Amrouche L; Rouzaud C; Lebreton X; Martinez F; Sberro-Soussan R; Legendre C; Zuber J; Anglicheau D
    Kidney Int; 2021 Feb; 99(2):486-488. PubMed ID: 33509358
    [No Abstract]   [Full Text] [Related]  

  • 6. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
    Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
    mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.
    Cuapio A; Boulouis C; Filipovic I; Wullimann D; Kammann T; Parrot T; Chen P; Akber M; Gao Y; Hammer Q; Strunz B; Pérez Potti A; Rivera Ballesteros O; Lange J; Muvva JR; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Söderdahl G; Österborg A; Smith CIE; Bogdanovic G; Muschiol S; Hellgren F; Loré K; Sobkowiak MJ; Gabarrini G; Healy K; Sällberg Chen M; Alici E; Björkström NK; Buggert M; Ljungman P; Sandberg JK; Aleman S; Ljunggren HG
    Mol Med; 2022 Feb; 28(1):20. PubMed ID: 35135470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.
    Parker EPK; Desai S; Marti M; Nohynek H; Kaslow DC; Kochhar S; O'Brien KL; Hombach J; Wilder-Smith A
    Lancet Glob Health; 2022 Mar; 10(3):e326-e328. PubMed ID: 35180408
    [No Abstract]   [Full Text] [Related]  

  • 9. Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection.
    Ratcliff J; Nguyen D; Fish M; Rynne J; Jennings A; Williams S; Al-Beidh F; Bonsall D; Evans A; Golubchik T; Gordon AC; Lamikanra A; Tsang P; Ciccone NA; Leuscher U; Slack W; Laing E; Mouncey PR; Ziyenge S; Oliveira M; Ploeg R; Rowan KM; Shankar-Hari M; Roberts DJ; Menon DK; Estcourt L; Simmonds P; Harvala H;
    J Infect Dis; 2021 Aug; 224(4):595-605. PubMed ID: 34031695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
    Liou TG; Adler FR; Cahill BC; Cox DR; Cox JE; Grant GJ; Hanson KE; Hartsell SC; Hatton ND; Helms MN; Jensen JL; Kartsonaki C; Li Y; Leung DT; Marvin JE; Middleton EA; Osburn-Staker SM; Packer KA; Shakir SM; Sturrock AB; Tardif KD; Warren KJ; Waddoups LJ; Weaver LJ; Zimmerman E; Paine R
    Physiol Rep; 2021 Feb; 9(4):e14761. PubMed ID: 33625796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load.
    Migueres M; Dimeglio C; Trémeaux P; Raymond S; Lhomme S; Da Silva I; Oliveira Mendes K; Abravanel F; Félicé MP; Mansuy JM; Izopet J
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
    Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Reinfection in An Immunosuppressed Patient Without An Antibody Response.
    Hunsinger DHP; Kutti Sridharan DG; Rokkam DVRP; Fantry DLE
    Am J Med Sci; 2021 Jul; 362(1):103. PubMed ID: 33612185
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged viral shedding in an immunocompetent patient with COVID-19.
    McKie AM; Jones TPW; Sykes C
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33012717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 persistence in immunocompromised children.
    Dolan SA; Mulcahy Levy J; Moss A; Pearce K; Butler M; Jung S; Dominguez SR; Mwangi E; Maloney K; Rao S
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29277. PubMed ID: 34453477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology.
    Chepurnov AA; Kazachinskaya EI; Kazachkova EA; Sharshov KA; Kononova YV; Shelemba AA; Alekseev AY; Gulyeva MA; Voevoda MI; Shestopalov AM
    Bull Exp Biol Med; 2021 Nov; 172(1):49-52. PubMed ID: 34787781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity.
    Achdout H; Vitner EB; Politi B; Melamed S; Yahalom-Ronen Y; Tamir H; Erez N; Avraham R; Weiss S; Cherry L; Bar-Haim E; Makdasi E; Gur D; Aftalion M; Chitlaru T; Vagima Y; Paran N; Israely T
    Nat Commun; 2021 Oct; 12(1):5819. PubMed ID: 34611155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients.
    Deng X; Evdokimova M; O'Brien A; Rowe CL; Clark NM; Harrington A; Reid GE; Uprichard SL; Baker SC
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.